TORONTO — The experimental drug obicetrapib, a potent oral cholesteryl ester transfer protein (CETP) inhibitor, significantly slowed Alzheimer’s disease (AD) biomarker progression over 12 months in ...
Montana just passed a new bill backed by longevity enthusiasts that will enable access to drugs and therapies that are not approved by the FDA. A bill that allows medical clinics to sell unproven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback